Evidence map›Paper›PMID 31336840›Full record

ReviewInternational journal of molecular sciences2019

Human DNA Virus Exploitation of the MAPK-ERK Cascade.

Jeanne K DuShane, Melissa S Maginnis

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. MAPK-ERK Pathway.International journal of molecular sciences · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jeanne K DuShaneDepartment of Molecular and Biomedical Sciences, The University of Maine, Orono, ME 04401, USA.
Melissa S MaginnisDepartment of Molecular and Biomedical Sciences, The University of Maine, Orono, ME 04401, USA. melissa.maginnis@maine.edu.
University of Maine · US

Funding

Characterization of Viral Receptors and Signaling Networks in JC Polyomavirus InfectionR15AI144686 · NIAID · UNIVERSITY OF MAINE ORONO · PI MAGINNIS, MELISSA · 2019 to 2022
$876k
NIAID NIH HHS R15 AI144686NIH HHS R15AI144686
6 · The paper itself

Abstract

The extracellular signal-regulated kinases (ERKs) comprise a particular branch of the mitogen-activated protein kinase cascades (MAPK) that transmits extracellular signals into the intracellular environment to trigger cellular growth responses. Similar to other MAPK cascades, the MAPK-ERK pathway signals through three core kinases-Raf, MAPK/ERK kinase (MEK), and ERK-which drive the signaling mechanisms responsible for the induction of cellular responses from extracellular stimuli including differentiation, proliferation, and cellular survival. However, pathogens like DNA viruses alter MAPK-ERK signaling in order to access DNA replication machineries, induce a proliferative state in the cell, or even prevent cell death mechanisms in response to pathogen recognition. Differential utilization of this pathway by multiple DNA viruses highlights the dynamic nature of the MAPK-ERK pathway within the cell and the importance of its function in regulating a wide variety of cellular fates that ultimately influence viral infection and, in some cases, result in tumorigenesis.

Indexed as

Host-Pathogen InteractionsMAP Kinase Signaling SystemDNA VirusesDNA Virus InfectionsExtracellular Signal-Regulated MAP KinasesHumansMitogen-Activated Protein KinasesProtein BindingExtracellular Signal-Regulated MAP KinasesMitogen-Activated Protein Kinasescellular signalinginfectionmitogen-activated protein kinaseviruses

Identifiers

PMID31336840
PMCPMC6679023
OpenAlexW2958546365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.